László Őrfi
- Oncology top 2%
- HER2/EGFR in Cancer Research 10
- Drug Transport and Resistance Mechanisms 7
- Hematology top 2%
- Genetics top 5%
- Molecular Biology top 5%
- Cancer therapeutics and mechanisms 9
- Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology 7
-
- Computational Drug Discovery Methods 11
-
- Lung Cancer Treatments and Mutations 10
-
- Quinazolinone synthesis and applications 9
- Synthesis and biological activity 7
- Co-authors
- Gÿorgý KériAndrás VáradiBalázs SarkadiCsilla Özvegy‐LaczkaAxel UllrichDániel ErösIstván SzabadkaiCynthia K. Larive
- Cited by
- OncologyHematologyGenetics
- Journals
- Current Medicinal Chemistry (8 papers)Bioorganic & Medicinal Chemistry Letters (5 papers)Journal of Medicinal Chemistry (4 papers)
- Partner nations
- HungaryGermanyUnited States
In The Last Decade
László Őrfi
111 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 138
- Oncology 1.0k
- Hematology 385
- Genetics 282
- Molecular Biology 1.6k
- Infectious Diseases 358
Countries citing papers authored by László Őrfi
This map shows the geographic impact of László Őrfi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by László Őrfi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites László Őrfi more than expected).
Fields of papers citing papers by László Őrfi
This network shows the impact of papers produced by László Őrfi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by László Őrfi. The network helps show where László Őrfi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside László Őrfi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 6 | |
| 2 | 2022 | 4 | |
| 3 | 2021 | 8 | |
| 4 | 2021 | 40 | |
| 5 | 2019 | 12 | |
| 6 | 2018 | 6 | |
| 7 | 2016 | 41 | |
| 8 | 2015 | 31 | |
| 9 | 2014 | 27 | |
| 10 | 2013 | 4 | |
| 11 | 2008 | 170 | |
| 12 | 2008 | 4 | |
| 13 | 2007 | 61 | |
| 14 | 2006 | 29 | |
| 15 | 2005 | 84 | |
| 16 | 2005 | 19 | |
| 17 | 2002 | 173 | |
| 18 | 2002 | 73 | |
| 19 | 2002 | 33 | |
| 20 | [Biological activity and structure of antitumor compounds from Plantago media L]. | 1999 | 12 |
About László Őrfi
László Őrfi is a scholar working on Oncology, Organic Chemistry, Molecular Biology, Computational Theory and Mathematics and Genetics, having authored 113 papers that have together received 3.3k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (11 papers), HER2/EGFR in Cancer Research (10 papers), Lung Cancer Treatments and Mutations (10 papers), Cancer therapeutics and mechanisms (9 papers), Quinazolinone synthesis and applications (9 papers), Synthesis and biological activity (7 papers), Tuberculosis Research and Epidemiology (7 papers) and Drug Transport and Resistance Mechanisms (7 papers). The work is most often cited by research in Oncology (1.0k citations), Hematology (385 citations), Genetics (282 citations), Molecular Biology (1.6k citations) and Infectious Diseases (358 citations). László Őrfi has collaborated with scholars based in Hungary, Germany and United States. Frequent co-authors include Gÿorgý Kéri, András Váradi, Balázs Sarkadi, Csilla Özvegy‐Laczka, Axel Ullrich, Dániel Erös, István Szabadkai, Cynthia K. Larive, Henrik Daub and Csaba Szántai-Kis. Their work appears in journals such as Current Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Journal of Chromatography B and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.